G
Gaby Palmer
Researcher at University of Geneva
Publications - 111
Citations - 7591
Gaby Palmer is an academic researcher from University of Geneva. The author has contributed to research in topics: Inflammation & Arthritis. The author has an hindex of 43, co-authored 99 publications receiving 6767 citations. Previous affiliations of Gaby Palmer include Geneva College.
Papers
More filters
Journal ArticleDOI
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells
Solenne Vigne,Gaby Palmer,Praxedis Martin,Céline Lamacchia,D. Strebel,Emiliana Rodriguez,Maria L. Olleros,Dominique Vesin,Irene Garcia,Francesca Ronchi,Federica Sallusto,John E. Sims,Cem Gabay +12 more
TL;DR: These findings point toward a critical function of IL-36 in the priming of Th1 cell responses in vitro, and in adaptive immunity in a model of mycobacterial infection in vivo.
Journal ArticleDOI
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Gaby Palmer,Brian P. Lipsky,Molly D. Smithgall,David Park Meininger,Sophia Siu,Dominique Talabot-Ayer,Cem Gabay,Dirk E. Smith +7 more
TL;DR: Immunoprecipitation confirmed that IL-33 specifically binds ST2 and revealed that cellular IL-1 receptor accessory protein (AcP) associates with ST2 in a ligand-dependent manner, identifying AcP as a shared co-receptor within theIL-1 family that is essential for IL-32 signaling and suggesting a novel role for sAcP in modulating the activity of IL- 33.
Journal ArticleDOI
Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation
Atsushi Suzuki,Jérôme Guicheux,Gaby Palmer,Yoshitaka Miura,Yutaka Oiso,Jean-Philippe Bonjour,J. Caverzasio +6 more
TL;DR: The data indicate that MAPKs regulate different stages of MC3T3-E1 cell development in response to FCS, with Erk playing an essential role in cell replication, whereas p38 is involved in the regulation of ALP expression during osteoblastic cell differentiation.
Journal ArticleDOI
Is IL-1 a good therapeutic target in the treatment of arthritis?
TL;DR: IL-1 blockade by anakinra is dramatically effective in systemic-onset juvenile idiopathic arthritis, in adult Still's disease and in several autoinflammatory disorders, most of the latter being caused by mutations of proteins controlling IL-1beta secretion.
Journal ArticleDOI
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes.
David Magne,Gaby Palmer,Jenny L. Barton,Françoise Mezin,Dominique Talabot-Ayer,Sylvette Bas,Trevor Duffy,Marcus Noger,Pierre-André Guerne,Martin J.H. Nicklin,Cem Gabay +10 more
TL;DR: IL-1F8 exerts proinflammatory effects in primary human joint cells, and it remains to be determined whether circulating IL-1f8 can contribute to joint inflammation in rheumatoid arthritis.